{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:31:26Z","timestamp":1790418686724,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93023C00040"],"award-info":[{"award-number":["75N93023C00040"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00044"],"award-info":[{"award-number":["75N93019C00044"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI168643"],"award-info":[{"award-number":["U19 AI168643"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1U01AI124284"],"award-info":[{"award-number":["1U01AI124284"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-004886"],"award-info":[{"award-number":["INV-004886"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jmb.2024.168446","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:32:59Z","timestamp":1705793579000},"page":"168446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders"],"prefix":"10.1016","volume":"436","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3648-9461","authenticated-orcid":false,"given":"Sanya","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4455-7842","authenticated-orcid":false,"given":"Jensen","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-7452","authenticated-orcid":false,"given":"Simon","family":"Doss-Gollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3112-0687","authenticated-orcid":false,"given":"Kevin","family":"Ryff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-7819","authenticated-orcid":false,"given":"Elisabeth","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-3975","authenticated-orcid":false,"given":"Gabriel K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-8639","authenticated-orcid":false,"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-1945","authenticated-orcid":false,"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1791-0161","authenticated-orcid":false,"given":"Simon D.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2024.168446_b0005","doi-asserted-by":"crossref","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos. Trans. Royal Soc. B Biol. Sci."},{"key":"10.1016\/j.jmb.2024.168446_b0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ni0504-460","article-title":"Vaccine development strategies for improving immunization: the role of modern immunology","volume":"5","author":"Levine","year":"2004","journal-title":"Nature Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0015","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2012.10.014","article-title":"Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly","volume":"37","author":"Kollmann","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jmb.2024.168446_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-21-1","article-title":"Inhibition of tumor necrosis factor alpha reduces the outgrowth of hepatic micrometastasis of colorectal tumors in a mouse model of liver ischemia-reperfusion injury","volume":"21","author":"Jiao","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jmb.2024.168446_b0030","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.4049\/jimmunol.1202207","article-title":"Developmental Expression of IL-12R\u03b22 on Murine Naive Neonatal T Cells Counters the Upregulation of IL-13R\u03b11 on Primary Th1 Cells and Balances Immunity in the Newborn","volume":"190","author":"Hoeman","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1203\/01.pdr.0000228319.10481.ea","article-title":"Innate immunity of the human newborn is polarized toward a high ratio of IL-6\/TNF-\u03b1 production in vitro and in vivo","volume":"60","author":"Angelone","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jmb.2024.168446_b0040","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4049\/jimmunol.177.3.1956","article-title":"The Adenosine system selectively inhibits TLR-mediated TNF-\u03b1 production in the human newborn","volume":"177","author":"Levy","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2024.168446_b0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000301938","article-title":"MicroRNA-146: tiny player in neonatal innate immunity?","volume":"99","author":"Lederhuber","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.jmb.2024.168446_b0055","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.4049\/jimmunol.1600282","article-title":"Age-specific adjuvant synergy: dual TLR7\/8 and mincle activation of human newborn dendritic cells enables Th1 polarization","volume":"197","author":"van Haren","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","article-title":"Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination","volume":"3","author":"Jo","year":"2023","journal-title":"Nature Aging."},{"key":"10.1016\/j.jmb.2024.168446_b0065","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"Cd8+ but Not Cd8\u2212 Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo","volume":"192","author":"den Haan","year":"2000","journal-title":"J Exp Medicine."},{"key":"10.1016\/j.jmb.2024.168446_b0070","doi-asserted-by":"crossref","DOI":"10.1084\/jem.143.5.1283","article-title":"Cross-priming for a secondary cytotoxic response to minor h antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay","volume":"143","author":"Bevan","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmb.2024.168446_b0075","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.172.4.1996","article-title":"Cutting edge: conventional CD8\u03b1+ dendritic cells are generally involved in priming CTL immunity to viruses","volume":"172","author":"Belz","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Giudice","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0085","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.vaccine.2009.01.118","article-title":"The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice","volume":"27","author":"Kovacs-Nolan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0090","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.vaccine.2009.01.117","article-title":"CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle","volume":"27","author":"Kovacs-Nolan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0095","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1099\/vir.0.011684-0","article-title":"Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice","volume":"90","author":"Kovacs-Nolan","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jmb.2024.168446_b0100","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JVI.79.4.2024-2032.2005","article-title":"Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine","volume":"79","author":"Oumouna","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2024.168446_b0105","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.vaccine.2009.05.094","article-title":"A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity","volume":"27","author":"Kindrachuk","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.addr.2008.12.013","article-title":"Innovative strategies for co-delivering antigens and CpG oligonucleotides","volume":"61","author":"Krishnamachari","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jmb.2024.168446_b0115","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-022-31709-2","article-title":"CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns","volume":"13","author":"van Haren","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2024.168446_b0120","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.4049\/jimmunol.1600282","article-title":"Age-specific adjuvant synergy: dual TLR7\/8 and mincle activation of human newborn dendritic cells enables Th1 polarization","volume":"197","author":"van Haren","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0125","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"Partnership","year":"2011","journal-title":"New Engl. J. Medicine."},{"key":"10.1016\/j.jmb.2024.168446_b0130","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an adjuvant system containing \u03b1-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"Gar\u00e7on","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmb.2024.168446_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101426","article-title":"The continued advance of vaccine adjuvants \u2013 \u2018we can work it out\u2019","volume":"50","author":"O\u2019Hagan","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-adjuvanted hepatitis B vaccine (HEPLISAV- B\u00ae) update","volume":"20","author":"Lee","year":"2021","journal-title":"Exp. Rev. Vaccines"},{"key":"10.1016\/j.jmb.2024.168446_b0150","doi-asserted-by":"crossref","first-page":"e91020","DOI":"10.1172\/jci.insight.91020","article-title":"TLR7\/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth","volume":"2","author":"Dowling","year":"2017","journal-title":"Jci Insight."},{"key":"10.1016\/j.jmb.2024.168446_b0155","doi-asserted-by":"crossref","first-page":"eabj5305","DOI":"10.1126\/scitranslmed.abj5305","article-title":"An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice","volume":"14","author":"Nanishi","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmb.2024.168446_b0160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaci.2015.02.030","article-title":"Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells","volume":"136","author":"Lemoine","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0165","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cyto.2016.04.001","article-title":"In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant","volume":"83","author":"van Haren","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jmb.2024.168446_b0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4049\/immunohorizons.2000081","article-title":"Human blood plasma shapes distinct neonatal TLR-mediated dendritic cell activation via expression of the MicroRNA Let-7g","volume":"5","author":"England","year":"2021","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jmb.2024.168446_b0180","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.4049\/jimmunol.1401243","article-title":"Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells","volume":"193","author":"Balan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0185","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20100348","article-title":"Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells","volume":"207","author":"Bachem","year":"2010","journal-title":"J Exp Medicine."},{"key":"10.1016\/j.jmb.2024.168446_b0190","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cell.2011.11.021","article-title":"Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells","volume":"147","author":"Cebrian","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2024.168446_b0195","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2024.168446_b0200","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/j.vaccine.2018.05.101","article-title":"A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model","volume":"36","author":"Gregg","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0205","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1080\/21645515.2015.1046659","article-title":"Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity","volume":"11","author":"Zhu","year":"2015","journal-title":"Hum Vacc Immunother."},{"key":"10.1016\/j.jmb.2024.168446_b0210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1073\/pnas.1112648109","article-title":"Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction","volume":"109","author":"Moon","year":"2012","journal-title":"Proc National Acad Sci."},{"key":"10.1016\/j.jmb.2024.168446_b0215","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"Goff","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2024.168446_b0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in Toll-like receptor signalling","volume":"430","author":"Beutler","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2024.168446_b0225","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2094","article-title":"Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake","volume":"9","author":"Liang","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmb.2024.168446_b0235","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.4049\/jimmunol.174.7.4373","article-title":"Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines","volume":"174","author":"Heit","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0240","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.it.2017.07.002","article-title":"MHC class I cross-presentation: stage lights on Sec22b","volume":"38","author":"Montealegre","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fimmu.2012.00014","article-title":"The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells","volume":"3","author":"Kroczek","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2024.168446_b0250","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.cell.2018.06.045","article-title":"Stereotypic immune system development in newborn children","volume":"174","author":"Olin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2024.168446_b0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/vaccines11010030","article-title":"Characterization of systemic and mucosal humoral immune responses to an adjuvanted intranasal SARS-CoV-2 protein subunit vaccine candidate in mice","volume":"11","author":"Maltseva","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jmb.2024.168446_b0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/vir.0.058461-0","article-title":"Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation","volume":"95","author":"Garg","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jmb.2024.168446_b0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2024.168446_b0270","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1016\/j.vaccine.2012.06.011","article-title":"Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles","volume":"30","author":"Garlapati","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2024.168446_b0275","unstructured":"Influenza (Flu) Vaccine (Live, Intranasal): What You Need to Know, (n.d.). https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/flulive.pdf."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283624000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283624000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:19:53Z","timestamp":1786216793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283624000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022283624000123"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2024.168446","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2024.168446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"168446"}}